Tampa, FLNCT02630121Now EnrollingIRB Ready

Sleep Apnea Clinical Trial in Tampa, FL

Access cutting-edge sleep apnea treatment through this phase 4 clinical trial at a research site in Tampa. Study-provided care at no cost to qualified participants.

Sponsored by University of South Florida

Quick Self-Assessment

See if you qualify for this Tampa location

Preparing your pre-screening questions…

Expert Care in Tampa

Access sleep apnea specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related sleep apnea treatment provided free

Apply for This Tampa Location

Check if you qualify for this sleep apnea clinical trial in Tampa, FL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Tampa

    Convenient for FL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Tampa site if eligible
  4. 4Begin participation

About This Sleep Apnea Study in Tampa

The addition of intranasal oxymetazoline for two weeks to already instituted optimal doses of intranasal fluticasone propionate will decrease the total number of obstructive apneas and hypopneas per hour of sleep in subjects with perennial allergic or non-allergic rhinitis and mild obstructive sleep apnea who have persistent nasal congestion despite maximum doses of NGCS.

Sponsor: University of South Florida

Who Can Participate

Inclusion Criteria

Male and female subjects 18 - 65 years of age.
At least a one year history of perennial allergic or non-allergic rhinitis.
Subjects must be on the maximum recommended doses of one of the following NGCS for at least one month. (See Table I)
AHI per hour of sleep \> 5 and \<15, minimum SpO2 88, indicating mild obstructive sleep apnea).
Average Nasal Congestion VAS of \> 3-10 indicating moderate to severe nasal congestion between visits 1 and 2 based on daily symptoms (average of 7 scores).
Average Congestion Quantifier 7 score of 7 between visits 1 and 2 based on weekly symptoms (average of 2 scores).
Willingness to participate as indicated by signed informed consent.

Exclusion Criteria

Presence of hypersensitivity to oxymetazoline or fluticasone propionate.
Subjects receiving allergen immunotherapy but not on a stable maintenance regimen for at least 30 days before the first study visit.
If the subject has perennial allergic rhinitis, he/she should not be entered into this study eight weeks before, during, or six weeks after any seasonal exacerbation.
Women who are pregnant or lactating.
Other known nasal diseases likely to affect deposition of oxymetazoline such as sinusitis, nasal polyps, or major nasal structural malformations.
Respiratory tract infections in the last 14 days.
Infections requiring antibiotics in the last 14 days.
Asthma or chronic obstructive pulmonary disease (COPD) requiring roflumilast or more than the recommended doses of inhaled corticosteroids, beta agonists, or antimuscarinic agents.
No systemic glucocorticosteroids for one month prior or during the study.
Cardiovascular disease with uncontrolled hypertension (BP160/80), arrhythmias and/or congestive heart failure.
Insulin-dependent diabetes mellitus and/or diabetic retinopathy.
Subjects with mild OSA (AHI 5-14) and SpO2 \<88 for \> 5 min during sleep that is identified during the screening portable sleep study.
Hypertension requiring more than two drugs, with the exception of hydrochlorothiazide, to achieve control.
A history of drug or alcohol abuse within the past 5 years.
Subjects who are currently abusing alcohol, illicit drugs, benzodiazepines, or narcotics.
Inability to cooperate, comply with study procedures or communicate with the investigator to successfully complete the study.
A history of benign prostate hypertrophy necessitating treatment.
A history of psychiatric problems which, in the opinion of the investigators, would impair participation in the study.
Subjects with a planned hospitalization during the study.
An infirmity, disability, or geographical location which seems likely to prevent regular attendance for subject visits.
Subjects with obstructive sleep apnea syndrome requiring CPAP therapy.
Subjects diagnosed with central sleep apnea (\> 5 central events per hour) or moderate to severe OSA (AHI \> 15) and SpO2 \<88 for \> 5 min during sleep identified during screening.
Use of the following medications within the time period specified below prior to Day -7 (Table 2).

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Tampa?

Yes, this clinical trial (NCT02630121) has an active research site in Tampa, FL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Sleep Apnea Treatment Options in Tampa, FL

If you're searching for sleep apnea treatment options in Tampa, FL, this clinical trial (NCT02630121) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Tampa research site is actively enrolling participants for this phase 4 clinical trial. You'll receive care from experienced sleep apnea specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all sleep apnea clinical trials near you to find additional studies recruiting in your area.

More Lupus Trials in Tampa, FL

See all lupus clinical trials recruiting in Tampa — not just this study.

Browse Lupus Trials in Tampa →

Browse More Trials by Condition

Lupus TrialsSleep Apnea TrialsPrurigo Nodularis TrialsSystemic Lupus Erythematosus TrialsAll Conditions →

Ready to Join in Tampa?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Tampa, FL